Press Releases Blog

Healthcare investment specialist ARCHIMED has the expertise, experience, enthusiasm and financial strength to fully back Instem’s ambitions.

New Software Module Introduced to Support the Latest Regulatory-approved Carcinogenic Potency Categorization Approach (CPCA)

New powerful technology and data sharing suite provides a range of translational science solutions

New functionality along with Enhanced Models to Deliver More Efficient and Comprehensive Predictions in Chemical Safety

Instem Secures Portion of €2.5m Grant as Member of Research Consortium Investigating the Mutagenicity of N-nitrosamines

Newly Added Services to Support Latest Regulatory Guidance and Growing Demand for Alternative Testing Methods